IntroMedic Co., Ltd.
KRX
₩5,850.00
+0.00%
Delayed · cached 15 min
✓Strengths
- Moderate debt: debt-to-equity of 0.91.
- Current assets comfortably cover current liabilities (current ratio 2.04).
!Watch-points
- Thin interest cover: operating profit covers interest only about -3.6 times.
- Return on equity is on the lower side at -33.4%.
- Return on capital employed is on the lower side at -24%.
- The company reported a net loss in the latest period.
- Sales growth has been slow over five years (about 2% a year).
These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.
Forensic Checks
Altman Z-ScoreDistress zone
-12.41
In Altman’s study, scores in this range were associated with a higher incidence of financial distress.
Computed without the market-value term.
Piotroski F-ScoreWeak
2 / 5
The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.
Based on 5 of the 9 signals — the rest need data not available for this stock.
These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.
Key Ratios
Current Price₩ 5,850.00
High / Low₩ 5,850.00 / 57.00
Book Value₩ 95.73
ROCE-24.00%
ROE-33.42%
Debt to Equity0.91
Current Ratio2.04
EPS₩ -31.99
PAT Margin-14.05%
ICR-3.58
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity